North America Veterinary Oncology Market By Animal Type (Canine and Feline) By Therapy (Chemotherapy, Radiology, Surgery, Immunotherapy and Others) By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others) By Country, Industry Analysis and Forecast, 2020 - 2026
The North America Veterinary oncology Market would witness market growth of 12.4% CAGR during the forecast period (2020-2026).
Veterinary radiation oncology continues to advance with the introduction of emerging technology, procedures, and guidelines while growing patient outcome knowledge. They do face gaps in expertise and require randomized clinical trials to evaluate true results for clinicians, prognostic factors, dose tolerances, and toxicity.
In animals, lymphoma (lymphosarcoma) is a type of cancer characterized by the proliferation of malignant lymphocytes in solid organs such as the lymph nodes, bone marrow, liver, and spleen. The disorder can also occur in the gastrointestinal tract of the body, skin, and. Close supervision of dogs receiving chemotherapy is necessary because of the high risk of recurrence and resulting problems. The same refers to dogs who have reached remission and have ceased treatment. Disease and remission/recurrence control is normally done by peripheral lymph node palpation. This detects significant changes in peripheral lymph nodes. Some of the blood testing used to detect lymphoma often provide more objectivity and provide an early warning of an animal coming out of remission.
Veterinary cancer treatments aim at eradicating the cancer cells that are present in pets. Based on the type of cancer, stage, and nature of the disease, the veterinarian recommends different treatments such as targeted therapy and combination therapy or chemotherapy. Researchers' ongoing research efforts for the development of new formulations and therapies are expected to stimulate the growth of the global veterinary oncology market. With the advent of tailored treatments, conventional cancer therapy can be revolutionized.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
Scope of the Study
Market Segmentation:
By Animal Type
Veterinary radiation oncology continues to advance with the introduction of emerging technology, procedures, and guidelines while growing patient outcome knowledge. They do face gaps in expertise and require randomized clinical trials to evaluate true results for clinicians, prognostic factors, dose tolerances, and toxicity.
In animals, lymphoma (lymphosarcoma) is a type of cancer characterized by the proliferation of malignant lymphocytes in solid organs such as the lymph nodes, bone marrow, liver, and spleen. The disorder can also occur in the gastrointestinal tract of the body, skin, and. Close supervision of dogs receiving chemotherapy is necessary because of the high risk of recurrence and resulting problems. The same refers to dogs who have reached remission and have ceased treatment. Disease and remission/recurrence control is normally done by peripheral lymph node palpation. This detects significant changes in peripheral lymph nodes. Some of the blood testing used to detect lymphoma often provide more objectivity and provide an early warning of an animal coming out of remission.
Veterinary cancer treatments aim at eradicating the cancer cells that are present in pets. Based on the type of cancer, stage, and nature of the disease, the veterinarian recommends different treatments such as targeted therapy and combination therapy or chemotherapy. Researchers' ongoing research efforts for the development of new formulations and therapies are expected to stimulate the growth of the global veterinary oncology market. With the advent of tailored treatments, conventional cancer therapy can be revolutionized.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
Scope of the Study
Market Segmentation:
By Animal Type
- Canine and
- Feline
- Chemotherapy
- Radiology
- Surgery
- Immunotherapy and
- Others
- Lymphoma
- Mast Cell Cancer
- Mammary & Squamous Cell Cancer and
- Others
- US
- Canada
- Mexico
- Rest of North America
- Boehringer Ingelheim International GmbH
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Varian Medical Systems, Inc.
- PetCure Oncology, LLC (Accelitech, LLC)
- AB Science SA
- Rhizen Pharmaceuticals S.A.
- Nippon Zenyaku Kogyo Co., Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Veterinary Oncology Market, by Animal Type
1.4.2 North America Veterinary Oncology Market, by Therapy
1.4.3 North America Veterinary Oncology Market, by Cancer Type
1.4.4 North America Veterinary Oncology Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Sep – 2019, Nov) Leading Players
CHAPTER 4. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE
4.1 North America Canine Market by Country
4.2 North America Feline Market by Country
CHAPTER 5. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY
5.1 North America Chemotherapy Market by Country
5.2 North America Radiology Market by Country
5.3 North America Surgery Market by Country
5.4 North America Immunotherapy Market by Country
5.5 North America Other Therapy Market by Country
CHAPTER 6. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE
6.1 North America Lymphoma Market by Country
6.2 North America Mast Cell Cancer Market by Country
6.3 North America Mammary & Squamous Cell Cancer Market by Country
6.4 North America Others Market by Country
CHAPTER 7. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY
7.1 US Veterinary Oncology Market
7.1.1 US Veterinary Oncology Market by Animal Type
7.1.2 US Veterinary Oncology Market by Therapy
7.1.3 US Veterinary Oncology Market by Cancer Type
7.2 Canada Veterinary Oncology Market
7.2.1 Canada Veterinary Oncology Market by Animal Type
7.2.2 Canada Veterinary Oncology Market by Therapy
7.2.3 Canada Veterinary Oncology Market by Cancer Type
7.3 Mexico Veterinary Oncology Market
7.3.1 Mexico Veterinary Oncology Market by Animal Type
7.3.2 Mexico Veterinary Oncology Market by Therapy
7.3.3 Mexico Veterinary Oncology Market by Cancer Type
7.4 Rest of North America Veterinary Oncology Market
7.4.1 Rest of North America Veterinary Oncology Market by Animal Type
7.4.2 Rest of North America Veterinary Oncology Market by Therapy
7.4.3 Rest of North America Veterinary Oncology Market by Cancer Type
CHAPTER 8. COMPANY PROFILES
8.1 Boehringer Ingelheim International GmbH
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Karyopharm Therapeutics, Inc.
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Regeneus Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.4 Elanco Animal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Zoetis, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Varian Medical Systems, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.5.2 Partnerships, Collaborations, and Agreements:
8.6.5.3 Product Launches and Product Expansions:
8.7 PetCure Oncology, LLC (Accelitech, LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 AB Science SA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expense
8.9 Rhizen Pharmaceuticals S.A.
8.9.1 Company Overview
8.1 Nippon Zenyaku Kogyo Co., Ltd.
8.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Veterinary Oncology Market, by Animal Type
1.4.2 North America Veterinary Oncology Market, by Therapy
1.4.3 North America Veterinary Oncology Market, by Cancer Type
1.4.4 North America Veterinary Oncology Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Sep – 2019, Nov) Leading Players
CHAPTER 4. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE
4.1 North America Canine Market by Country
4.2 North America Feline Market by Country
CHAPTER 5. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY
5.1 North America Chemotherapy Market by Country
5.2 North America Radiology Market by Country
5.3 North America Surgery Market by Country
5.4 North America Immunotherapy Market by Country
5.5 North America Other Therapy Market by Country
CHAPTER 6. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE
6.1 North America Lymphoma Market by Country
6.2 North America Mast Cell Cancer Market by Country
6.3 North America Mammary & Squamous Cell Cancer Market by Country
6.4 North America Others Market by Country
CHAPTER 7. NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY
7.1 US Veterinary Oncology Market
7.1.1 US Veterinary Oncology Market by Animal Type
7.1.2 US Veterinary Oncology Market by Therapy
7.1.3 US Veterinary Oncology Market by Cancer Type
7.2 Canada Veterinary Oncology Market
7.2.1 Canada Veterinary Oncology Market by Animal Type
7.2.2 Canada Veterinary Oncology Market by Therapy
7.2.3 Canada Veterinary Oncology Market by Cancer Type
7.3 Mexico Veterinary Oncology Market
7.3.1 Mexico Veterinary Oncology Market by Animal Type
7.3.2 Mexico Veterinary Oncology Market by Therapy
7.3.3 Mexico Veterinary Oncology Market by Cancer Type
7.4 Rest of North America Veterinary Oncology Market
7.4.1 Rest of North America Veterinary Oncology Market by Animal Type
7.4.2 Rest of North America Veterinary Oncology Market by Therapy
7.4.3 Rest of North America Veterinary Oncology Market by Cancer Type
CHAPTER 8. COMPANY PROFILES
8.1 Boehringer Ingelheim International GmbH
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Karyopharm Therapeutics, Inc.
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Regeneus Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.4 Elanco Animal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Zoetis, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Varian Medical Systems, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.5.2 Partnerships, Collaborations, and Agreements:
8.6.5.3 Product Launches and Product Expansions:
8.7 PetCure Oncology, LLC (Accelitech, LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 AB Science SA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expense
8.9 Rhizen Pharmaceuticals S.A.
8.9.1 Company Overview
8.1 Nippon Zenyaku Kogyo Co., Ltd.
8.10.1 Company Overview
LIST OF TABLES
TABLE 1 NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– VETERINARY ONCOLOGY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– VETERINARY ONCOLOGY MARKET
TABLE 5 MERGERS & ACQUISITIONS – VETERINARY ONCOLOGY MARKET
TABLE 6 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 7 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 8 NORTH AMERICA CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 9 NORTH AMERICA CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 10 NORTH AMERICA FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 11 NORTH AMERICA FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 12 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 13 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 14 NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 15 NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 16 NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 17 NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 18 NORTH AMERICA SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 19 NORTH AMERICA SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 20 NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 21 NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 22 NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 23 NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 24 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 25 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 26 NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 27 NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 28 NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 29 NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 30 NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 31 NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 32 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 33 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 34 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 35 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 36 US VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 37 US VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 38 US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 39 US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 40 US VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 41 US VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 42 US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 43 US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 44 CANADA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 45 CANADA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 46 CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 47 CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 48 CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 49 CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 50 CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 51 CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 52 MEXICO VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 53 MEXICO VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 54 MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 55 MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 56 MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 57 MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 58 MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 59 MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 60 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 61 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 62 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 63 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 64 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 65 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 66 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 67 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 68 KEY INFORMATION – BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 69 KEY INFORMATION – KARYOPHARM THERAPEUTICS, INC.
TABLE 70 KEY INFORMATION – REGENEUS LTD.
TABLE 71 KEY INFORMATION – ELANCO ANIMAL HEALTH, INC.
TABLE 72 KEY INFORMATION – ZOETIS, INC.
TABLE 73 KEY INFORMATION –-VARIAN MEDICAL SYSTEMS, INC.
TABLE 74 KEY INFORMATION – PETCURE ONCOLOGY, LLC
TABLE 75 KEY INFORMATION – AB SCIENCE SA
TABLE 76 KEY INFORMATION – RHIZEN PHARMACEUTICALS S.A.
TABLE 77 KEY INFORMATION – NIPPON ZENYAKU KOGYO CO., LTD.
TABLE 1 NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– VETERINARY ONCOLOGY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– VETERINARY ONCOLOGY MARKET
TABLE 5 MERGERS & ACQUISITIONS – VETERINARY ONCOLOGY MARKET
TABLE 6 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 7 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 8 NORTH AMERICA CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 9 NORTH AMERICA CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 10 NORTH AMERICA FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 11 NORTH AMERICA FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 12 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 13 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 14 NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 15 NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 16 NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 17 NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 18 NORTH AMERICA SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 19 NORTH AMERICA SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 20 NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 21 NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 22 NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 23 NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 24 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 25 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 26 NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 27 NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 28 NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 29 NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 30 NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 31 NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 32 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 33 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 34 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 35 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 36 US VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 37 US VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 38 US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 39 US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 40 US VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 41 US VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 42 US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 43 US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 44 CANADA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 45 CANADA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 46 CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 47 CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 48 CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 49 CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 50 CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 51 CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 52 MEXICO VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 53 MEXICO VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 54 MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 55 MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 56 MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 57 MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 58 MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 59 MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 60 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 61 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 62 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 63 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 64 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 65 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 66 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 67 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 68 KEY INFORMATION – BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 69 KEY INFORMATION – KARYOPHARM THERAPEUTICS, INC.
TABLE 70 KEY INFORMATION – REGENEUS LTD.
TABLE 71 KEY INFORMATION – ELANCO ANIMAL HEALTH, INC.
TABLE 72 KEY INFORMATION – ZOETIS, INC.
TABLE 73 KEY INFORMATION –-VARIAN MEDICAL SYSTEMS, INC.
TABLE 74 KEY INFORMATION – PETCURE ONCOLOGY, LLC
TABLE 75 KEY INFORMATION – AB SCIENCE SA
TABLE 76 KEY INFORMATION – RHIZEN PHARMACEUTICALS S.A.
TABLE 77 KEY INFORMATION – NIPPON ZENYAKU KOGYO CO., LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, SEP – 2019, NOV) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, SEP – 2019, NOV) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.
